Vallon Pharmaceuticals, Inc. Human Resources Contracts & Agreements
21 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (2)
- Consulting Agreements (4)
- Employment Agreements (6)
- Separation Agreements (1)
- Amendment No. 1 to Employment Agreement, dated June 17, 2024, between the Company and Albert Agro, Ph.D (Filed With SEC on June 18, 2024)
- Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on December 4, 2023)
- Employment Agreement, by and between GRI Bio, Inc. and Albert Agro, Ph.D., dated as of July 1, 2023 (Filed With SEC on August 14, 2023)
- A&R 2018 Equity Incentive Plan (Filed With SEC on May 15, 2023)
- Separation Agreement, dated April 21, 2023, by and between GRI Bio, Inc. and David Baker (Filed With SEC on April 21, 2023)
- Amended and Restated GRI Bio, Inc. 2018 Equity Incentive Plan (Filed With SEC on April 21, 2023)
- Consulting Agreement, by and between GRI Bio, Inc. and Albert Agro, M.D., dated as of January 9, 2023 (Filed With SEC on April 21, 2023)
- GRI Bio, Inc. 2015 Equity Incentive (Filed With SEC on December 23, 2022)
- Consulting and Scientific Advisory Board Agreement, by and between GRI Bio, Inc. and Vipin Kumar Chaturvedi, personally or through Vidur Discoveries LLC, dated as of October 31 (Filed With SEC on December 23, 2022)
- Consulting and Clinical Advisory Board Agreement, by and between GRI Bio, Inc. and Rohit Loomba, M.D., dated as of June 3 (Filed With SEC on December 23, 2022)
- Incentive Stock Option Agreement by and between GRI Bio, Inc. and Sean Edwards, dated as of November 4 (Filed With SEC on December 23, 2022)
- Non-Employee Director Compensation Program of Vallon Pharmaceuticals, Inc., effective on June 9, 2022 (Filed With SEC on July 28, 2022)
- Employment Agreement, dated as of May 10, 2021, by and between the Company and Leanne M. Kelly (Filed With SEC on May 13, 2021)
- Employment Agreement, dated as of April 20, 2021, by and between the Company and David Baker (Filed With SEC on May 13, 2021)
- Form of Nonqualified Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on January 14, 2021)
- Employment Agreement between Vallon Pharmaceuticals, Inc. and David Baker, dated January 15, 2019 (Filed With SEC on January 14, 2021)
- Employment Agreement between Vallon Pharmaceuticals, Inc. and Penny S. Toren, dated April 2, 2018 (Filed With SEC on January 14, 2021)
- Consulting Agreement with Whitaker Biopharmaceutical Consulting LLC, dated April 2, 2018 (Filed With SEC on January 14, 2021)
- Form of Incentive Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)
- Form of Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)
- Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)
